MORGAN STANLEY - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 7.84 and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$1,411,000
-85.4%
74,823
-90.9%
0.00%
-100.0%
Q2 2019$9,662,000
-15.0%
820,896
-1.5%
0.00%0.0%
Q1 2019$11,373,000
+15.8%
833,186
-13.1%
0.00%0.0%
Q4 2018$9,825,000
-47.8%
958,520
-15.2%
0.00%
-40.0%
Q3 2018$18,815,000
-24.8%
1,130,036
-28.6%
0.01%
-28.6%
Q2 2018$25,021,000
+64.6%
1,583,660
+32.3%
0.01%
+75.0%
Q1 2018$15,197,000
+14.7%
1,196,623
+3.4%
0.00%0.0%
Q4 2017$13,246,000
+37.6%
1,156,837
+47.2%
0.00%
+33.3%
Q3 2017$9,629,000
+14.5%
786,069
+7.0%
0.00%0.0%
Q2 2017$8,411,000
-20.7%
734,579
+44.0%
0.00%
+50.0%
Q1 2017$10,610,000
-20.4%
510,010
-20.4%
0.00%0.0%
Q4 2016$13,322,000
+294.0%
640,590
+520.7%
0.00%
+100.0%
Q3 2016$3,381,000
+1152.2%
103,212
+854.0%
0.00%
Q2 2016$270,000
+19.5%
10,819
+17.3%
0.00%
Q1 2016$226,000
+5.6%
9,222
+42.7%
0.00%
Q4 2015$214,000
-97.2%
6,464
-97.2%
0.00%
-100.0%
Q3 2015$7,610,000
-44.5%
232,272
-10.3%
0.00%
-40.0%
Q2 2015$13,716,000
+376.4%
258,924
+159.6%
0.01%
+400.0%
Q1 2015$2,879,000
+1173.9%
99,735
+1182.6%
0.00%
Q4 2014$226,000
+1406.7%
7,776
+540.0%
0.00%
Q3 2014$15,000
-99.1%
1,215
-98.5%
0.00%
-100.0%
Q2 2014$1,592,00079,3190.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,628,328$33,869,00014.72%
Foresite Capital Management II, LLC 995,396$20,704,00010.39%
Cormorant Asset Management, LP 1,581,604$32,897,0004.43%
DAFNA Capital Management LLC 221,013$4,597,0004.04%
New Leaf Venture Partners, L.L.C. 228,428$4,751,0003.40%
Partner Investment Management, L.P. 63,571$1,322,0001.75%
Iguana Healthcare Management, LLC 140,000$2,912,0001.74%
PFM Health Sciences, LP 2,913,951$60,610,0001.71%
Redmile Group, LLC 920,550$19,147,0001.65%
SECTORAL ASSET MANAGEMENT INC 669,351$13,923,0001.54%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders